185 related articles for article (PubMed ID: 12861131)
1. Effects of trimonthly progestin administration on the endometrium in elderly postmenopausal women who receive hormone replacement therapy: a pilot study.
Pinto AB; Binder EF; Kohrt WM; Bronder DR; Williams DB
Am J Obstet Gynecol; 2003 Jul; 189(1):11-5. PubMed ID: 12861131
[TBL] [Abstract][Full Text] [Related]
2. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
[TBL] [Abstract][Full Text] [Related]
3. Comparison of transvaginal ultrasonography and endometrial biopsy in endometrial surveillance in postmenopausal HRT users.
Hänggi W; Bersinger N; Altermatt HJ; Birkhäuser MH
Maturitas; 1997 Jun; 27(2):133-43. PubMed ID: 9255748
[TBL] [Abstract][Full Text] [Related]
4. Uterine effects of raloxifene in comparison with continuous-combined hormone replacement therapy in postmenopausal women.
Fugère P; Scheele WH; Shah A; Strack TR; Glant MD; Jolly E
Am J Obstet Gynecol; 2000 Mar; 182(3):568-74. PubMed ID: 10739509
[TBL] [Abstract][Full Text] [Related]
5. Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy. The Ogen/Provera Study Group.
Nand SL; Webster MA; Baber R; O'Connor V
Obstet Gynecol; 1998 May; 91(5 Pt 1):678-84. PubMed ID: 9572210
[TBL] [Abstract][Full Text] [Related]
6. Endometrial response in estrogen replacement therapy quarterly combined with a progestogen.
Boerrigter PJ; van de Weijer PH; Baak JP; Fox H; Haspels AA; Kenemans P
Maturitas; 1996 May; 24(1-2):63-71. PubMed ID: 8794436
[TBL] [Abstract][Full Text] [Related]
7. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
[TBL] [Abstract][Full Text] [Related]
8. Assessment of less than monthly progestin therapy in postmenopausal women given estrogen replacement.
Williams DB; Voigt BJ; Fu YS; Schoenfeld MJ; Judd HL
Obstet Gynecol; 1994 Nov; 84(5):787-93. PubMed ID: 7936513
[TBL] [Abstract][Full Text] [Related]
9. The effects of progesterone and progestins on endometrial proliferation.
Moyer DL; Felix JC
Contraception; 1998 Jun; 57(6):399-403. PubMed ID: 9693400
[TBL] [Abstract][Full Text] [Related]
10. Cyclic hormone replacement therapy using quarterly progestin.
Ettinger B; Selby J; Citron JT; Vangessel A; Ettinger VM; Hendrickson MR
Obstet Gynecol; 1994 May; 83(5 Pt 1):693-700. PubMed ID: 8164927
[TBL] [Abstract][Full Text] [Related]
11. Transvaginal sonography of the endometrium in postmenopausal women: monitoring the effect of hormone replacement therapy.
Castelo-Branco C; Puerto B; Durán M; Gratacós E; Torné A; Fortuny A; Vanrell JA
Maturitas; 1994 May; 19(1):59-65. PubMed ID: 7935033
[TBL] [Abstract][Full Text] [Related]
12. Endometrial safety and bleeding pattern during a five-year treatment with long-cycle hormone therapy.
Odmark IS; Bixo M; Englund D; Risberg B; Jonsson B; Olsson SE
Menopause; 2005; 12(6):699-707. PubMed ID: 16278613
[TBL] [Abstract][Full Text] [Related]
13. Sequential combined transdermal and oral postmenopausal hormone replacement therapies: effects on bleeding patterns and endometrial histology.
Sendag F; Terek MC; Karadadas N
Arch Gynecol Obstet; 2001 Nov; 265(4):209-13. PubMed ID: 11789748
[TBL] [Abstract][Full Text] [Related]
14. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
Langer RD; Landgren BM; Rymer J; Helmond FA;
Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644
[TBL] [Abstract][Full Text] [Related]
15. Agreement in assessing endometrial pathology: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
Legault C; Espeland MA; Wasilauskas CH; Bush TL; Trabal J; Judd HL; Johnson SR; Greendale GA
J Womens Health; 1998 May; 7(4):435-42. PubMed ID: 9611701
[TBL] [Abstract][Full Text] [Related]
16. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
[TBL] [Abstract][Full Text] [Related]
17. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of transvaginal uterine ultrasound and endometrial biopsy for evaluating the endometrium of postmenopausal women taking hormone replacement therapy.
Archer DF; Lobo RA; Land HF; Pickar JH
Menopause; 1999; 6(3):201-8. PubMed ID: 10486789
[TBL] [Abstract][Full Text] [Related]
19. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.
JAMA; 1996 Nov; 276(17):1389-96. PubMed ID: 8892713
[TBL] [Abstract][Full Text] [Related]
20. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding: is it always necessary to perform an endometrial biopsy?
Gull B; Carlsson S; Karlsson B; Ylöstalo P; Milsom I; Granberg S
Am J Obstet Gynecol; 2000 Mar; 182(3):509-15. PubMed ID: 10739500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
